ASBP Aspire BioPharma, Inc.
Company Analysis
Latest News
🟢 Aspire BioPharma is trading 7.5% up today amid thin after-hours liquidity
Aspire BioPharma is trading at $6.03 (+7.49%) in after-hours trading following a sharp selloff during the regular session. • No company-specific catalysts,...
🔴 Aspire BioPharma is trading 17.9% down today amid broader market pressure
Aspire BioPharma is trading at $5.95 (-17.87%) amid broader market pressure and a risk-off trading environment, as no company-specific catalysts were...
🔴 Aspire BioPharma is trading 5.5% down today as earlier biotech rally fades
Aspire BioPharma is trading at $6.85 (down 5.5%) as the stock retraces gains from an earlier sector-wide biotech rally. • The move follows a strong...
🟢 Aspire BioPharma is trading 5.7% up today amid a broad biotech rally fueled by M&A optimism
Aspire BioPharma is trading at $7.37 (5.74% up) as the biotech group catches a bid during a broad sector rally. • The biotech sector is up 2.31% on optimism...
🔴 Aspire BioPharma is trading 10.5% down today on continued downside momentum
Aspire BioPharma is trading at $6.50 (10.5% down) in after-hours trading, extending a period of sharp volatility and a significant decline seen earlier this...
🔴 Aspire BioPharma is trading 10.8% down
Aspire BioPharma is trading at $6.92, down 10.8% from a comparison close of $7.76 during regular trading. This is a price-action follow-up, so a separate...
🔴 Aspire BioPharma is trading 10.5% down
Aspire BioPharma is trading at $6.75, down 10.5% from a comparison close of $7.54 during pre-market. This is a price-action follow-up, so a separate catalyst...
🟢 Aspire BioPharma is trading 12.3% up
Aspire BioPharma is trading at $7.39, up 12.3% from a comparison close of $6.58 during regular trading. This is a price-action follow-up, so a separate...
🟢 Aspire BioPharma is trading 5% up today, extending a two-day rebound after a sharp selloff
Aspire BioPharma is trading at $6.91 (up 5%) as of July 21, 2026, continuing a two-day recovery following a period of significant downward pressure. • The...
🟢 Aspire BioPharma is trading 5.7% up today despite no clear company-specific catalyst
Aspire BioPharma is trading at $6.59 (+5.69%) despite a lack of company-specific news, earnings, or regulatory announcements to explain the move. • No...
🟢 Aspire BioPharma is trading 6.1% up today on quiet news flow
Aspire BioPharma is trading 6.1% up at $6.41 on relatively quiet news flow. • There are no fresh company-specific headlines, earnings reports, FDA actions, or...
🟢 Aspire BioPharma surges 7.4% on positive sentiment following recent acquisition news
Aspire BioPharma is trading 7.4% up at $6.21 today, likely fueled by positive sentiment stemming from the company's recent definitive agreement to acquire Dura...
🔴 Aspire BioPharma is trading 5.71% down today with no clear catalyst
Aspire BioPharma is trading 5.71% down at $5.45 in pre-market after a weak follow-through from the prior session’s $5.78 close. • No company-specific...
🔴 ASBP is trading 9.9% down today as it extends pullback from late-June speculative gains
ASBP is trading 9.9% down at $5.30 as the stock extends its recent pullback from late-June speculative gains and financing-driven volatility. • The move...
🔴 ASBP is trading 5.2% down today in a pullback after recent speculative gains
ASBP is trading at $5.89 (5.2% down) in pre-market as the stock pulls back from a recent volatile stretch. • The decline follows a period of sharp gains tied...
🔴 ASBP is trading 6.3% down today on profit-taking and broader market softness
ASBP is trading at $5.49, down 6.3% today as the stock gives back a portion of its recent sharp rally. • The stock surged 9.74% on July 01, 2026, but faced...
🔴 ASBP is trading 6% down today on profit-taking after a regular-session rally
ASBP is trading at $5.51, down 5.97% in after-hours trading, as the stock gives back a portion of its 9.74% regular-session gain amid broader market...
🟢 ASBP is trading 5.3% up today as traders refocus on FDA pre-IND optimism
ASBP is trading 5.3% up at $5.62 as the stock rebounds from a sharp drop in the prior session linked to concerns over its planned acquisition of Dura Driver...
🟢 ASBP is trading 6.7% up today as it recovers from acquisition concerns and eyes FDA momentum
ASBP is trading 6.7% up at $5.70 in pre-market, bouncing after yesterday’s sharp drop tied to fading optimism around its planned Dura Driver Control Systems...
🔴 ASBP is trading 13.19% down today as momentum traders unwind following fading enthusiasm for the Dura Driver deal
ASBP is trading at $5.33 (-13.19%) as momentum traders unwind a volatile rally following fading enthusiasm for the planned Dura Driver Control Systems...